{"id":"beccea77-2608-5b0e-8449-7a67884871b0","stable_key":"9ee3c90a-c675-5dce-a105-4dc6909dfeab:ifnb-apt2-protein","predicate":"has_contextual_experimental_result","statement":"Recombinant mouse IFN-beta increased APT2 protein expression in peritoneal macrophages.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"5e5727b5-ec22-5051-9920-88451b247c26","mechanism_event_label":"ifnb-apt2-protein","subject":{"id":"fdfc9a08-b208-563f-8cc2-e367f9689f06","slug":"mouse-ifnb1","display_name":"Mouse interferon beta / IFNB1","entity_type_key":"cytokine"},"object":{"id":"377f43e3-59a4-52ae-bf1e-9da9d8b91cd3","slug":"mouse-apt2-abundance","display_name":"APT2 protein abundance in mouse cells","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"5e5727b5-ec22-5051-9920-88451b247c26","stable_key":"9ee3c90a-c675-5dce-a105-4dc6909dfeab:ifnb-apt2-protein","event_type":"experimental_result","label":"ifnb-apt2-protein","description":"Recombinant mouse IFN-beta increased APT2 protein expression in peritoneal macrophages.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"fdfc9a08-b208-563f-8cc2-e367f9689f06","slug":"mouse-ifnb1","display_name":"Mouse interferon beta / IFNB1","entity_type_key":"cytokine"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"377f43e3-59a4-52ae-bf1e-9da9d8b91cd3","slug":"mouse-apt2-abundance","display_name":"APT2 protein abundance in mouse cells","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"1345a511-9164-5363-ad1e-5b0212c0259d","slug":"mouse-lypla2","display_name":"Mouse acyl-protein thioesterase 2 / LYPLA2","entity_type_key":"protein"},"role":"induced protein","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"experimental_model","value_text":"Mouse peritoneal exudate macrophages","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Recombinant IFN-beta at 0, 3, 6 and 12 hours (Figure 7c visually reviewed); exact dose unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"No measurement of APT2 membrane localization, catalytic flux or GPX4 turnover. Protein induction does not establish increased activity toward every APT2 substrate.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"organism","value_text":"Mouse","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_locator","value_text":"Figure 7c; immunoblot and corresponding Results.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"https://doi.org/10.1038/s41467-025-65081-8","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"20ef81b6-b5c3-5503-a8c0-b8b0c3ca4457","evidence_kind":"source_excerpt","locator":"Lines 87-93","start_line":87,"end_line":93,"excerpt":"Recombinant mouse IFN-beta increased APT2 protein expression in peritoneal macrophages.\nprimary_references: https://doi.org/10.1038/s41467-025-65081-8\nprimary_locator: Figure 7c; immunoblot and corresponding Results.\norganism: Mouse\nexperimental_model: Mouse peritoneal exudate macrophages\nexposure: Recombinant IFN-beta at 0, 3, 6 and 12 hours (Figure 7c visually reviewed); exact dose unresolved.\nlimitations: No measurement of APT2 membrane localization, catalytic flux or GPX4 turnover. Protein induction does not establish increased activity toward every APT2 substrate.","model_system":"Mouse peritoneal exudate macrophages","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Curator paraphrase of primary result and assay context.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"dcc74980-d350-5911-b545-8c47ecdcf8fd","stable_key":"import-9ee3c90a-c675-5dce-a105-4dc6909dfeab","title":"MAVS inhibitor nulls and APT2-TBK1 immune feedback","document_type":"imported_text","citation_label":"Selected primary observations: 10.1073/pnas.2403392121; 10.1038/s41467-025-65081-8.","file_path":"","sha256":"16b3ee62ea6e0331133d1f7e9adbf7569a58fcbfda2b64c25a12f0dc4cdf4fe6","revision_id":"a5ea594c-6318-5060-b1c7-26e57336aa8d","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}